Amphastar Pharmaceuticals Ownership | Who Owns Amphastar Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Amphastar Pharmaceuticals Ownership Summary


Amphastar Pharmaceuticals is owned by 11.87% institutional investors, 24.30% insiders, and 63.84% retail investors. Blackrock is the largest institutional shareholder, holding 12.33% of AMPH shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.71% of its assets in Amphastar Pharmaceuticals shares.

AMPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAmphastar Pharmaceuticals11.87%24.30%63.84%
SectorHealthcare Stocks 231.98%10.74%-142.72%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.82%11.62%67.56%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock5.94M12.33%$237.70M
Blackrock funding, inc. /de5.46M11.75%$146.27M
Vanguard group2.61M5.61%$69.85M
Td asset management1.96M4.22%$52.57M
Dimensional fund advisors lp1.80M3.87%$48.20M
State street1.50M3.20%$39.99M
Fuller & thaler asset management1.39M3.00%$37.34M
Epoch investment partners1.13M2.42%$30.22M
Boston trust walden1.09M2.34%$29.12M
Geode capital management886.83K1.91%$23.75M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lam group130.80K2.00%$3.50M
Bridge city capital235.49K1.85%$6.31M
Mesirow institutional investment management380.39K1.09%$14.12M
Quantedge capital pte45.10K0.66%$1.20M
Denali advisors211.76K0.63%$5.67M
Summerhaven investment management38.20K0.58%$1.02M
Illumine investment management28.33K0.55%$758.62K
Significant wealth partners9.62K0.29%$257.73K
Systematic financial management lp435.58K0.28%$11.66M
Boston trust walden1.09M0.22%$29.12M

Top Buyers

HolderShares% AssetsChange
Millennium management868.55K0.01%612.00K
Goldman sachs group556.71K0.00%315.48K
Clark capital management group283.67K0.05%283.67K
Algert global392.90K0.18%268.61K
Bridgeway capital management312.34K0.18%227.22K

Top Sellers

HolderShares% AssetsChange
Neuberger berman group---1.37M
Boston partners---423.07K
Granite investment partners---375.78K
Boone capital management---316.56K
Royal bank of canada49.67K0.00%-269.05K

New Positions

HolderShares% AssetsChangeValue
Clark capital management group283.67K0.05%283.67K$7.56M
Rice hall james & associates129.34K0.19%129.34K$3.45M
Brandywine global investment management105.42K0.02%105.42K$2.82M
Cibc world market62.19K0.00%62.19K$1.67M
Quantedge capital pte45.10K0.66%45.10K$1.20M

Sold Out

HolderChange
Financial gravity asset management-1.00
Sjs investment consulting-1.00
Caitong asset management-3.00
Jfs wealth advisors-3.00
Wealthtrak capital management-5.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202576-68.98%5,515,721-83.16%110.24%31-74.17%32-63.64%
Sep 30, 2025104-55.93%8,585,305-72.26%180.42%45-65.91%47-33.80%
Jun 30, 2025237-2.47%32,613,359-1.94%691.43%13214.78%70-25.53%
Mar 31, 20255-98.12%1,063,934-97.00%20.04%3-97.50%2-98.02%
Dec 31, 2024261-7.45%35,408,7620.08%721.38%116-18.31%1007.53%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF2.15M4.71%-360.82K
FullerThaler Behavioral Small-Cap Equity1.29M2.83%82.70K
FullerThaler Behavioral Sm-Cp Eq R61.29M2.83%82.70K
Vanguard Total Stock Mkt Idx Inv1.11M2.43%-
Vanguard US Total Market Shares ETF1.14M2.40%1.24K
TD U.S. Capital Reinvestment I1.02M2.23%-20.41K
TD Epoch U.S. Quality Capital Reinvestmt981.53K2.15%961.57K
iShares Russell 2000 ETF868.40K1.90%43.03K
Avantis US Small Cap Value ETF761.17K1.67%2.19K
Neuberger Berman Genesis Inv794.66K1.65%-271.05K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 17, 2025Zhou Rong SENIOR EVP, PRODUCTION CENTERSell$256.38K
Dec 12, 2025Petersen Floyd F.-Sell$62.89K
Dec 11, 2025Petersen Floyd F.-Sell$44.62K
Nov 25, 2025PRINS RICHARD K-Sell$113.25K
Nov 13, 2025Petersen Floyd F.-Sell$441.84K

Insider Transactions Trends


DateBuySell
2025 Q4-7
2025 Q3-3
2025 Q2-3
2025 Q1-2
2024 Q4-7

AMPH Ownership FAQ


Who Owns Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals shareholders are primarily institutional investors at 11.87%, followed by 24.30% insiders and 63.83% retail investors. The average institutional ownership in Amphastar Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.82%, which Amphastar Pharmaceuticals falls below.

Who owns the most shares of Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals’s largest shareholders are Blackrock (5.94M shares, 12.33%), Blackrock funding, inc. /de (5.46M shares, 11.75%), and Vanguard group (2.61M shares, 5.61%). Together, they hold 29.69% of Amphastar Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amphastar Pharmaceuticals?

Yes, BlackRock owns 12.33% of Amphastar Pharmaceuticals, totaling 5.94M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 237.7M$. In the last quarter, BlackRock decreased its holdings by -137K shares, a -2.25% change.

Who is Amphastar Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Lam group is Amphastar Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.00% of its assets in 130.8K Amphastar Pharmaceuticals shares, valued at 3.5M$.

Who is the top mutual fund holder of Amphastar Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Amphastar Pharmaceuticals shares, with 4.71% of its total shares outstanding invested in 2.15M Amphastar Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools